Edgestream Partners’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.79M Sell
135,978
-158,903
-54% -$3.64M 0.08% 433
2026
Q1
$6.5M Buy
294,881
+270,836
+1,126% +$4.71M 0.21% 152
2025
Q4
$283K Buy
+24,045
New +$309K 0.01% 891
2025
Q2
Sell
-256,716
Closed -$3.47M 867
2025
Q1
$3.47M Buy
+256,716
New +$4.26M 0.12% 337
2024
Q2
Sell
-46,778
Closed -$1.23M 865
2024
Q1
$1.23M Buy
+46,778
New +$1.33M 0.06% 454
2023
Q3
Sell
-25,895
Closed -$955K 831
2023
Q2
$955K Buy
+25,895
New +$790K 0.09% 365

Other funds holding CC

Edgestream Partners's CC Position: Q2 2026 in Review

Edgestream Partners reduced its Chemours (CC) stake by 54% in Q2 2026, selling an estimated $3.64M and leaving 135,978 shares worth $2.79M. The position accounts for 0.08% of the portfolio, ranked #433.

Edgestream Partners first reported a position in CC in Q2 2023 and has held it in 6 quarters since. The position peaked at $6.5M in Q1 2026. 469 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Edgestream Partners held 135,978 shares of Chemours worth $2.79M as of Q2 2026.
  • Edgestream Partners sold 158,903 Chemours shares in Q2 2026, an estimated $3.64M.
  • Chemours made up 0.08% of Edgestream Partners's portfolio in Q2 2026, its #433 holding.
  • Edgestream Partners first reported a position in Chemours in Q2 2023 and has held it in 6 quarters since.
  • Edgestream Partners's Chemours position peaked at $6.5M in Q1 2026.
  • 469 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Edgestream Partners's 13F filing for Q2 2026, filed 11 Aug 2026.